Acuta Capital Partners’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-123,000
Closed -$4.13M 48
2020
Q2
$4.13M Sell
123,000
-157,120
-56% -$6.67M 1.19% 30
2020
Q1
$11.3M Sell
280,120
-75,880
-21% -$3.55M 5.47% 5
2019
Q4
$14.6M Sell
356,000
-210,500
-37% -$6.16M 3.62% 9
2019
Q3
$12.2M Buy
566,500
+15,500
+3% +$380K 8.81% 3
2019
Q2
$12.1M Buy
551,000
+237,000
+75% +$4.98M 4.31% 7
2019
Q1
$4.63M Buy
+314,000
New +$5.57M 2.2% 19

Other funds holding ARVN

Acuta Capital Partners's ARVN Position: Q3 2020 in Review

Acuta Capital Partners sold out of Arvinas (ARVN) in Q3 2020, closing a stake of 123,000 shares — an estimated $4.13M sold.

Acuta Capital Partners first reported a position in ARVN in Q1 2019 and held it in 6 quarters. The position peaked at $14.6M in Q4 2019. 141 funds tracked by Wall St. Rank hold ARVN as of Q3 2020.

  • Acuta Capital Partners reported no remaining Arvinas position as of Q3 2020 after selling out during the quarter.
  • Acuta Capital Partners sold 123,000 Arvinas shares in Q3 2020, an estimated $4.13M.
  • Acuta Capital Partners first reported a position in Arvinas in Q1 2019 and held it in 6 quarters.
  • Acuta Capital Partners's Arvinas position peaked at $14.6M in Q4 2019.
  • 141 funds tracked by Wall St. Rank held Arvinas as of Q3 2020.

Based on Acuta Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.